Tech Company M&A Transactions
Trubion Pharmaceuticals Acquisition
Headquartered in Seattle, Trubion Pharmaceuticals was acquired by Emergent BioSolutions. The acquisition price was $96.8 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/13/2010
Transaction Type
M&A
Amount
$96,800,000
M&A Terms
Under the terms of the agreement each share of Trubion Pharmaceuticals common stock will be converted into the right to receive an up-front payment of $1.365 per share in cash and 0.1641 shares of Emergent BioSolutions' common stock. The up-front payment represents a value of $4.55 per share, or approximately $96.8 million.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2401 4th Ave 1050
Seattle, WA 98121
USA
Seattle, WA 98121
USA
Phone
Website
Email Address
Overview
Trubion Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines to treat inflammatory disease and cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Gillis
Chief Financial Officer
Michelle Burris
Chief Medical Officer
Scott Stromatt
VP - General Counsel
Kathleen Deeley
VP - R & D
Kendall Mohler
Browse more venture capital transactions:
Prev: 8/13/2010: WePay venture capital transaction
Next: 8/13/2010: Tower Cloud venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs